"Dr. Nathan Thompson examines blood panel of a patient before and after vaccination. The results are alarming!"
https://rumble.com/vna86v-immunity-t...d-vaccine.html
Printable View
"Dr. Nathan Thompson examines blood panel of a patient before and after vaccination. The results are alarming!"
https://rumble.com/vna86v-immunity-t...d-vaccine.html
I got halfway through it and then couldn't take the awful video quality any more, you could hardly even see the chart he was trying to show, it was horrible with all the pixelating. It's too bad he wasn't more concerned with making a quality video along with putting out these important findings. It's a shame, I would have saved it to share it to some of these goof balls who only spout off what they think they know from watching MSM.
I almost can't believe CDC or similar wouldn't have done testing like that during the trials.
Well it was rushed there was lots that they didn't know . We learned alot from the real live trials.Quote:
Originally Posted by Fisherman
Sent from my CLT-L04 using Tapatalk
I'd believe it without question. It wouldn't fit their or big pharma's agenda.Quote:
Originally Posted by Fisherman
Does explain why there is so many breakthrough cases in Isreal...and increasing here.
Also explains they there are so many Adverse affects from the vaccine
see: https://www.oodmag.com/community/sho...-19-in-Ontario
And yes there is truth to his findings...
https://www.ctvnews.ca/health/corona...ning-1.5659930Quote:
BARRIE -- Health Canada is updating the labels on two of the COVID-19 vaccines approved for use in Canada, to add the autoimmune disorder known as immune thrombocytopenia (ITP) as a potential side effect.
In an advisory issued Tuesday, Health Canada said it is updating the label of the Janssen (Johnson & Johnson) COVID-19 vaccine to “provide additional information about the very rare risk of ITP” and the “rare risk of venous thromboembolism (VTE)” after vaccination.
The label on the Vazxeveria vaccine made by AstraZeneca is also being updated to provide additional information about the “very rare risk” of thrombocytopenia, “including the very rare risk of ITP following vaccination,” the agency said.